GD
GDS.PA Ramsay Generale De Sante
- Market cap
- EUR 976M
- P/E
- -
- P/B
- 0.87x
- ROE
- -4.3%
- Dividend yield
- -
- Fundamental score
- 1.8/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is GDS.PA undervalued?
Graham numberThe Graham number of Ramsay Generale De Sante cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ramsay Generale De Sante fundamental analysis
6 of 11 checks passedROE 1/2
ROE in an average range (4.02%) suggests satisfactory profitability and decent utilization of shareholders' equity.
ROA 1/2
The stock's ROA (1.06%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.
PBV 1/2
The stock's PBV ratio (1.84x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.
DER 0/2
The company has a high debt to equity ratio (333%), which means it owes a lot of money compared to what it actually owns, making it financially risky.
Revenue Growth 2/2
With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.
Net Profit Growth 0/2
Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.
Assets Growth 1/2
This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.
Graham Number 0/1
The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.
Dividend Growth 0/2
The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.
Dividend 0/2
Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.
Buffet Intrinsic Value 1/1
The company's stock presents an enticing opportunity as it appears undervalued (3.291) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Ramsay Generale De Sante stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ramsay Generale De Sante
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. It provides preventive care, primary medicine, medicine surgery obstetrics, oncology, medical imaging, medical care and rehabilitation, home hospitalization, mental health care and addiction treatment, geriatrics, tele monitoring and e health services; and operates medical centres, and mental health day care centres. The company was formerly known as Générale de Santé SA…
Full company profileRamsay Generale De Sante financial statements
Ramsay Generale De Sante annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 2.23B | 2.24B | 3.40B | 3.75B | 4.02B | 4.30B | 4.70B | 5.01B | 5.24B | 5.38B |
| Gross Profit | 1.79B | 1.79B | 2.76B | 3.01B | 3.20B | 3.41B | 3.72B | 3.94B | 4.08B | 4.23B |
| Operating Income | 133M | 126M | 157M | 185M | 272M | 281M | 218M | 184M | 187M | 197M |
| EBITDA | 268M | 256M | 295M | 533M | 596M | 677M | 647M | 585M | 600M | 628M |
| Net Income | 57.0M | 7.30M | 15.3M | 18.7M | 65.0M | 118M | 49.4M | -53.9M | -54.1M | -48.3M |
| EPS | 0.70 | 0.10 | 0.18 | 0.17 | 0.59 | 1.07 | 0.45 | -0.49 | -0.49 | -0.42 |
| Balance Sheet | ||||||||||
| Total Assets | 2.35B | 2.50B | 4.36B | 6.71B | 6.68B | 6.79B | 6.96B | 6.90B | 6.84B | 6.68B |
| Total Liabilities | 1.84B | 1.99B | 3.32B | 5.68B | 5.58B | 5.55B | 5.68B | 5.67B | 5.66B | 5.53B |
| Shareholders' Equity | 462M | 470M | 996M | 1.01B | 1.07B | 1.21B | 1.25B | 1.19B | 1.15B | 1.12B |
| Cash & Short-term Investments | 183M | 308M | 378M | 548M | 620M | 144M | 363M | 381M | 384M | 311M |
| Total Debt | 1.15B | 1.26B | 2.02B | 3.92B | 3.85B | 3.97B | 4.15B | 4.06B | 4.08B | 4.05B |
| Cash Flow | ||||||||||
| Operating Cash Flow | 209M | 214M | 214M | 730M | 652M | 263M | 599M | 587M | 694M | 525M |
| Capital Expenditure | 102M | 62.6M | 178M | 169M | 176M | 194M | 172M | 169M | 143M | 144M |
| Free Cash Flow | 107M | 151M | 35.6M | 561M | 476M | 68.9M | 427M | 418M | 551M | 381M |
| Ratios | ||||||||||
| ROE | 12.3% | 1.6% | 1.5% | 1.8% | 6.1% | 9.8% | 4.0% | -4.5% | -4.7% | -4.3% |
| ROA | 2.4% | 0.3% | 0.4% | 0.3% | 1.0% | 1.7% | 0.7% | -0.8% | -0.8% | -0.7% |
| Net Profit Margin | 2.6% | 0.3% | 0.4% | 0.5% | 1.6% | 2.8% | 1.1% | -1.1% | -1.0% | -0.9% |
| Debt to Equity | 2.50x | 2.68x | 2.03x | 3.87x | 3.60x | 3.27x | 3.33x | 3.40x | 3.57x | 3.62x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ramsay Generale De Sante dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 2, 2014
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | EUR 4.80M | 0.06 | 8.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1013:940 on Mar 25, 2019.
Who owns Ramsay Generale De Sante
- Insiders 59.47%
- Institutions 39.92%
- Public & others 0.61%
- Shares outstanding 110M
- Free float 771K
Ramsay Generale De Sante company profile
- Company name
- Ramsay Generale De Sante
- Ticker
- GDS.PA
- ISIN
- FR0000044471
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 40,597
- Fiscal year end
- June
- Address
- Immeuble REIWA, Saint-Ouen-sur-Seine, France, 93400
- Phone
- 33 1 87 86 21 52
- Website
- ramsaygds.fr
About Ramsay Generale De Sante
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. It provides preventive care, primary medicine, medicine surgery obstetrics, oncology, medical imaging, medical care and rehabilitation, home hospitalization, mental health care and addiction treatment, geriatrics, tele monitoring and e health services; and operates medical centres, and mental health day care centres. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. The company was founded in 1987 and is headquartered in Saint-Ouen-sur-Seine, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.
Ramsay Generale De Sante management
10- Mr. Pascal RocheChief Executive Officer · born 1962
- Mr. Clement LafaixGroup Chief Financial Officer
- Mr. Pierre DuperatDirector of Group Investments and Risks · born 1969
- Ms. Isabelle MetrefHead of Investor Relations
- Ms. Laurence Pinot-LacanGroup Legal Director & Secretary of the Board of Director
- Mr. Henrik BrehmerGroup Director of Strategy & Public Affairs · born 1964
- Ms. Brigitte CachonGroup Impact & Sustainability Director
- Mr. Jerome BriceManaging Director of France
- Ms. Margareta DaneliusChief Medical Officer · born 1964
- Maria ArnouxChief of Staff to Pascal Roché